Evidence map›Paper›PMID 36454608›Full record

ArticleJournal of medical Internet research2022

Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis.

Steven T Simon, Katy E Trinkley, Daniel C Malone, Michael Aaron Rosenberg

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Steven T SimonDivision of Cardiology, University of Colorado School of Medicine, Aurora, CO, United States.ORCID 0000-0001-5385-3574
Katy E TrinkleyDepartment of Clinical Pharmacy, School of Pharmacy, University of Colorado, Aurora, CO, United States.ORCID 0000-0003-2041-7404
Daniel C MaloneCollege of Pharmacy, University of Utah, Salt Lake City, UT, United States.ORCID 0000-0002-5006-9394
Michael Aaron RosenbergDivision of Cardiac Electrophysiology, University of Colorado School of Medicine, Aurora, CO, United States.ORCID 0000-0002-6708-1648
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Utah · US

Funding

Development of End-To-End Clinical Decision Support Tools To Prevent Cardiotoxic Drug ResponseR01HL146824 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ROSENBERG, MICHAEL A · 2020 to 2024
$3.9M
Mentored Education for Dissemination and Implementation Science (MEDIS) ProgramR25DK123008 · NIDDK · WASHINGTON UNIVERSITY · PI BROWNSON, ROSS C, HAIRE-JOSHU, DEBRA · 2020 to 2024
$1.1M
Personalizing Clinical Decision Support for Heart Failure Treatment to Clinicians' NeedsK23HL161352 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Katy E Trinkley · 2022 to 2026
$869k
NHLBI NIH HHS K23 HL161352NHLBI NIH HHS R01 HL146824NIDDK NIH HHS R25 DK123008
6 · The paper itself

Abstract

backgroundDrug-induced long-QT syndrome (diLQTS) is a major concern among patients who are hospitalized, for whom prediction models capable of identifying individualized risk could be useful to guide monitoring. We have previously demonstrated the feasibility of machine learning to predict the risk of diLQTS, in which deep learning models provided superior accuracy for risk prediction, although these models were limited by a lack of interpretability.

objectiveIn this investigation, we sought to examine the potential trade-off between interpretability and predictive accuracy with the use of more complex models to identify patients at risk for diLQTS. We planned to compare a deep learning algorithm to predict diLQTS with a more interpretable algorithm based on cluster analysis that would allow medication- and subpopulation-specific evaluation of risk.

methodsWe examined the risk of diLQTS among 35,639 inpatients treated between 2003 and 2018 with at least 1 of 39 medications associated with risk of diLQTS and who had an electrocardiogram in the system performed within 24 hours of medication administration. Predictors included over 22,000 diagnoses and medications at the time of medication administration, with cases of diLQTS defined as a corrected QT interval over 500 milliseconds after treatment with a culprit medication. The interpretable model was developed using cluster analysis (K=4 clusters), and risk was assessed for specific medications and classes of medications. The deep learning model was created using all predictors within a 6-layer neural network, based on previously identified hyperparameters.

resultsAmong the medications, we found that class III antiarrhythmic medications were associated with increased risk across all clusters, and that in patients who are noncritically ill without cardiovascular disease, propofol was associated with increased risk, whereas ondansetron was associated with decreased risk. Compared with deep learning, the interpretable approach was less accurate (area under the receiver operating characteristic curve: 0.65 vs 0.78), with comparable calibration.

conclusionsIn summary, we found that an interpretable modeling approach was less accurate, but more clinically applicable, than deep learning for the prediction of diLQTS. Future investigations should consider this trade-off in the development of methods for clinical prediction.

Indexed as

Electronic Health RecordsLong QT SyndromeCluster AnalysisElectrocardiographyHumansMachine LearningAIartificial intelligencedeep learningdrug-induced QT prolongationEHRelectronic health recordsinterpretable machine learningMLmonitoringpredictionpredictive modelingrisk

Identifiers

PMID36454608
PMCPMC9756119
OpenAlexW4310526485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.